Suppr超能文献

西班牙裔人群中四种含黄素单加氧酶同工酶2(FMO2)多态性的单倍型及功能分析。

Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.

作者信息

Krueger Sharon K, Siddens Lisbeth K, Henderson Marilyn C, Andreasen Eric A, Tanguay Robert L, Pereira Clifford B, Cabacungan Erwin T, Hines Ronald N, Ardlie Kristin G, Williams David E

机构信息

Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.

出版信息

Pharmacogenet Genomics. 2005 Apr;15(4):245-56. doi: 10.1097/01213011-200504000-00008.

Abstract

OBJECTIVES

Previous work defined two flavin-containing monooxygenase 2 (FMO2) alleles. The major allele, FMO22 (g.23,238C>T), encodes truncated inactive protein (p.X472) whereas the minor allele, FMO21, present in African- and Hispanic-American populations, encodes active protein (p.Q472). Recently, four common (27 to 51% incidence) FMO2 single nucleotide polymorphisms (SNPs) were detected in African-Americans (N=50); they encode the following protein variants: p.71Ddup, p.V113fs, p.S195L and p.N413 K. Our objectives were to: (1) determine the incidence of these SNPs in 29 Hispanic individuals previously genotyped as g.23,238C (p.Q472) and 124 previously genotyped as homozygous g.23,238 T (p.X472); (2) determine FMO2 haplotypes in this population; and (3) assess the functional impact of SNPs in expressed proteins.

METHODS

SNPs were detected via allele-specific oligonucleotide amplification coupled with real-time or electrophoretic product detection, or single strand conformation polymorphism.

RESULTS

The g.7,700_7,702dupGAC SNP (p.71Ddup) was absent. The remaining SNPs were present but, except for g.13,732C>T (p.S195L), were less common in the current Hispanic study population versus the previously described African-Americans. Only expressed p.N413 K was as active as p.Q472, as determined by methimazole- and ethylenethiourea-dependent oxidation. Haplotype determination demonstrated that the g.10,951delG (p.V113fs), g.13,732C>T (p.S195L) and g.22,060T>G (p.N413 K) variants segregated with g.23,238C>T (p.X472).

CONCLUSIONS

SNPs would not alter FMO2 activity in individuals possessing at least one FMO21 allele. It is likely that these SNPs will segregate similarly in African-American populations. Therefore, estimates that 26% of African-Americans and 2-7% of Hispanic-Americans have at least one FMO21 allele should closely reflect the percentages producing active FMO2 protein.

摘要

目的

先前的研究确定了两个含黄素单加氧酶2(FMO2)等位基因。主要等位基因FMO22(g.23,238C>T)编码截短的无活性蛋白(p.X472),而次要等位基因FMO21存在于非裔美国人和西班牙裔美国人中,编码活性蛋白(p.Q472)。最近,在非裔美国人(N = 50)中检测到四个常见的(发生率为27%至51%)FMO2单核苷酸多态性(SNP);它们编码以下蛋白质变体:p.71Ddup、p.V113fs、p.S195L和p.N413K。我们的目标是:(1)确定这些SNP在29名先前基因分型为g.23,238C(p.Q472)的西班牙裔个体和124名先前基因分型为纯合g.23,238T(p.X472)的个体中的发生率;(2)确定该人群中的FMO2单倍型;(3)评估SNP对表达蛋白功能的影响。

方法

通过等位基因特异性寡核苷酸扩增结合实时或电泳产物检测或单链构象多态性检测SNP。

结果

g.7,700_7,702dupGAC SNP(p.71Ddup)不存在。其余SNP存在,但除了g.13,732C>T(p.S195L)外,在当前西班牙裔研究人群中比先前描述的非裔美国人中更少见。通过甲巯咪唑和乙撑硫脲依赖性氧化测定,只有表达的p.N413K与p.Q472一样具有活性。单倍型测定表明,g.10,951delG(p.V113fs)、g.13,732C>T(p.S195L)和g.22,060T>G(p.N413K)变体与g.23,238C>T(p.X472)共分离。

结论

SNP不会改变至少拥有一个FMO21等位基因个体的FMO2活性。这些SNP在非裔美国人中可能也会以类似方式共分离。因此,估计26%的非裔美国人和2 - 7%的西班牙裔美国人至少拥有一个FMO21等位基因,这应该能准确反映产生活性FMO2蛋白的百分比。

相似文献

1
Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.
Pharmacogenet Genomics. 2005 Apr;15(4):245-56. doi: 10.1097/01213011-200504000-00008.
2
Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent.
Drug Metab Dispos. 2004 Dec;32(12):1337-40. doi: 10.1124/dmd.104.001099. Epub 2004 Sep 8.
8
Genetic polymorphisms of flavin-containing monooxygenase (FMO).
Drug Metab Rev. 2002 Aug;34(3):523-32. doi: 10.1081/dmr-120005653.
9
Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants.
J Pharmacol Exp Ther. 2007 Jan;320(1):266-73. doi: 10.1124/jpet.106.112268. Epub 2006 Oct 18.
10
Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide.
Biochem Pharmacol. 2014 May 1;89(1):141-7. doi: 10.1016/j.bcp.2014.02.006. Epub 2014 Feb 19.

引用本文的文献

5
Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones.
Toxicol Appl Pharmacol. 2014 Jul 15;278(2):91-9. doi: 10.1016/j.taap.2014.04.002. Epub 2014 Apr 12.
6
Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide.
Biochem Pharmacol. 2014 May 1;89(1):141-7. doi: 10.1016/j.bcp.2014.02.006. Epub 2014 Feb 19.
8
Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes.
Toxicol Appl Pharmacol. 2008 Dec 15;233(3):420-7. doi: 10.1016/j.taap.2008.09.017. Epub 2008 Oct 1.
9
Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms.
Biochem Pharmacol. 2008 Jan 15;75(2):570-9. doi: 10.1016/j.bcp.2007.09.006. Epub 2007 Sep 8.
10
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.
Pharmacol Ther. 2005 Jun;106(3):357-87. doi: 10.1016/j.pharmthera.2005.01.001.

本文引用的文献

1
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.
Pharmacol Ther. 2005 Jun;106(3):357-87. doi: 10.1016/j.pharmthera.2005.01.001.
2
Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent.
Drug Metab Dispos. 2004 Dec;32(12):1337-40. doi: 10.1124/dmd.104.001099. Epub 2004 Sep 8.
4
The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development.
Drug Discov Today. 2004 Jul 1;9(13):574-81. doi: 10.1016/S1359-6446(04)03136-8.
6
The New York Cancer Project: rationale, organization, design, and baseline characteristics.
J Urban Health. 2004 Jun;81(2):301-10. doi: 10.1093/jurban/jth116.
8
A comparison of bayesian methods for haplotype reconstruction from population genotype data.
Am J Hum Genet. 2003 Nov;73(5):1162-9. doi: 10.1086/379378. Epub 2003 Oct 20.
10
Genotyping and site-directed mutagenesis of a cytochrome P450 meander Pro-X-Arg motif critical to CYP4B1 catalysis.
Toxicol Appl Pharmacol. 2003 Jan 15;186(2):119-26. doi: 10.1016/s0041-008x(02)00028-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验